MAI Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
128,741
+5,819
+5% +$469K 0.04% 338
2026
Q1
$10.7M Sell
122,922
-4,403
-3% -$422K 0.06% 266
2025
Q4
$12.2M Buy
127,325
+4,610
+4% +$448K 0.07% 237
2025
Q3
$11.7M Buy
122,715
+2,617
+2% +$241K 0.07% 228
2025
Q2
$10.5M Sell
120,098
-1,410
-1% -$120K 0.07% 218
2025
Q1
$10.9M Buy
121,508
+1,307
+1% +$117K 0.08% 208
2024
Q4
$9.6M Buy
120,201
+61,695
+105% +$5.34M 0.07% 226
2024
Q3
$5.27M Sell
58,506
-8,284
-12% -$697K 0.05% 248
2024
Q2
$5.26M Buy
66,790
+11,614
+21% +$952K 0.05% 253
2024
Q1
$4.81M Buy
55,176
+9,603
+21% +$820K 0.05% 259
2023
Q4
$3.75M Sell
45,573
-2,724
-6% -$208K 0.05% 238
2023
Q3
$3.78M Sell
48,297
-2,281
-5% -$191K 0.06% 221
2023
Q2
$4.46M Sell
50,578
-2,601
-5% -$224K 0.07% 203
2023
Q1
$4.29M Sell
53,179
-7,738
-13% -$631K 0.07% 199
2022
Q4
$4.73M Sell
60,917
-13,385
-18% -$1.08M 0.08% 186
2022
Q3
$6M Sell
74,302
-4,793
-6% -$431K 0.11% 150
2022
Q2
$7.1M Sell
79,095
-65,208
-45% -$6.61M 0.14% 131
2022
Q1
$16M Buy
144,303
+5,060
+4% +$535K 0.27% 88
2021
Q4
$14.4M Buy
139,243
+4,975
+4% +$576K 0.23% 96
2021
Q3
$16.8M Buy
134,268
+1,124
+0.8% +$145K 0.32% 80
2021
Q2
$16.5M Buy
133,144
+6,910
+5% +$868K 0.33% 81
2021
Q1
$14.9M Buy
126,234
+5,470
+5% +$641K 0.33% 77
2020
Q4
$14.1M Buy
120,764
+5,287
+5% +$582K 0.35% 71
2020
Q3
$12M Buy
115,477
+13,738
+14% +$1.38M 0.35% 75
2020
Q2
$9.33M Buy
101,739
+13,689
+16% +$1.31M 0.29% 78
2020
Q1
$7.94M Buy
88,050
+41,853
+91% +$4.45M 0.32% 73
2019
Q4
$5.24M Buy
46,197
+5,925
+15% +$650K 0.17% 114
2019
Q3
$4.37M Sell
40,272
-4,203
-9% -$439K 0.19% 112
2019
Q2
$4.33M Buy
44,475
+14,177
+47% +$1.29M 0.2% 115
2019
Q1
$2.76M Sell
30,298
-2,632
-8% -$236K 0.14% 133
2018
Q4
$3M Buy
32,930
+168
+0.5% +$15.7K 0.17% 124
2018
Q3
$3.22M Sell
32,762
-1,385
-4% -$128K 0.16% 127
2018
Q2
$2.92M Sell
34,147
-210
-0.6% -$17.5K 0.16% 134
2018
Q1
$2.76M Buy
34,357
+3,161
+10% +$261K 0.16% 138
2017
Q4
$2.52M Sell
31,196
-831
-3% -$66.6K 0.14% 138
2017
Q3
$2.49M Sell
32,027
-2,446
-7% -$203K 0.15% 134
2017
Q2
$3.06M Sell
34,473
-10,913
-24% -$920K 0.2% 115
2017
Q1
$3.66M Sell
45,386
-107,280
-70% -$8.38M 0.25% 107
2016
Q4
$10.9M Buy
152,666
+13,428
+10% +$1.05M 0.79% 32
2016
Q3
$12M Sell
139,238
-1,449
-1% -$126K 0.91% 29
2016
Q2
$12.2M Sell
140,687
-14,241
-9% -$1.15M 0.94% 29
2016
Q1
$11.6M Buy
154,928
+996
+0.6% +$75K 0.89% 33
2015
Q4
$11.8M Sell
153,932
-22,687
-13% -$1.71M 0.9% 28
2015
Q3
$11.8M Buy
176,619
+10,717
+6% +$789K 0.89% 31
2015
Q2
$12.3M Sell
165,902
-2,358
-1% -$180K 0.81% 34
2015
Q1
$13.1M Buy
168,260
+12,798
+8% +$970K 0.88% 29
2014
Q4
$11.2M Sell
155,462
-7,816
-5% -$543K 0.79% 44
2014
Q3
$10.1M Sell
163,278
-18,252
-10% -$1.16M 0.97% 35
2014
Q2
$11.6M Sell
181,530
-6,641
-4% -$403K 1.11% 31
2014
Q1
$11.6M Sell
188,171
-3,361
-2% -$196K 1.17% 29
2013
Q4
$11M Sell
191,532
-11,249
-6% -$638K 1.17% 32
2013
Q3
$10.8M Buy
202,781
+12,566
+7% +$676K 1.4% 22
2013
Q2
$9.79M Buy
+190,215
New +$9.4M 1.28% 32

Other funds holding MDT

MAI Capital Management's MDT Position: Q2 2026 in Review

MAI Capital Management increased its Medtronic (MDT) stake by 4.7% in Q2 2026, buying an estimated $469K and bringing the position to 128,741 shares worth $10.1M. The position accounts for 0.04% of the portfolio, ranked #338.

MAI Capital Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.8M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • MAI Capital Management held 128,741 shares of Medtronic worth $10.1M as of Q2 2026.
  • MAI Capital Management bought 5,819 Medtronic shares in Q2 2026, an estimated $469K.
  • Medtronic made up 0.04% of MAI Capital Management's portfolio in Q2 2026, its #338 holding.
  • MAI Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • MAI Capital Management's Medtronic position peaked at $16.8M in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.